ISABEL CASTREJÓN FERNÁNDEZ-rekin lankidetzan egindako argitalpenak (19)

2024

  1. Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register

    Seminars in Arthritis and Rheumatism, Vol. 64

  2. Opioids and fibromyalgia: frequency of use and factors associated with increased consumption in patients remitted to a tertiary care center

    BMC Musculoskeletal Disorders, Vol. 25, Núm. 1

2023

  1. Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: A monocentric survey'

    Annals of the Rheumatic Diseases

  2. Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study

    RMD open, Vol. 9, Núm. 1

  3. Impact of ultrasound limitation to assess aortitis in patients with giant cell arteritis: comparative study with FDG-PET/CT

    RMD open, Vol. 9, Núm. 3

  4. Oral or pulse glucocorticoid use at the onset of giant cell arteritis and its influence on the risk of relapse: a retrospective study

    Rheumatology International, Vol. 43, Núm. 7, pp. 1333-1340

  5. Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care

    RMD open, Vol. 9, Núm. 2

  6. The role of ultrasound and FDG-PET/CT to detect extracranial artery involvement in patients with suspected large vessel vasculitis

    Modern rheumatology, Vol. 33, Núm. 3, pp. 549-556

2022

  1. Diagnostic value of ultrasound halo count and Halo Score in giant cell arteritis: A retrospective study from routine care

    Annals of the Rheumatic Diseases

  2. Impact of cardiovascular risk on the diagnostic accuracy of the ultrasound Halo Score for giant cell arteritis

    Arthritis Research and Therapy, Vol. 24, Núm. 1

  3. Prevalence of post-COVID-19 in patients with fibromyalgia: a comparative study with other inflammatory and autoimmune rheumatic diseases

    BMC Musculoskeletal Disorders, Vol. 23, Núm. 1

  4. Ultrasound intima media thickness cut-off values for cranial and extracranial arteries in patients with suspected giant cell arteritis

    Frontiers in Medicine, Vol. 9

2021

  1. Clinical impact of confinement due to the COVID-19 pandemic on patients with fibromyalgia: A cohort study

    Clinical and Experimental Rheumatology, Vol. 39, Núm. 3

  2. Clinical impact of musculoskeletal ultrasound on rheumatoid arthritis in routine care

    International Journal of Rheumatic Diseases, Vol. 24, Núm. 3, pp. 341-346

  3. Subclavian artery involvement in patients with giant cell arteritis: do we need a modified Halo Score?

    Clinical Rheumatology, Vol. 40, Núm. 7, pp. 2821-2827

  4. Ultrasound in clinically suspect arthralgia: the role of power Doppler to predict rheumatoid arthritis development

    Arthritis Research and Therapy, Vol. 23, Núm. 1

2020

  1. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: A multicentric matched cohort study

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 12, pp. 1544-1549

  2. Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes

    Rheumatology International, Vol. 40, Núm. 10, pp. 1593-1598

  3. Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 9, pp. 1170-1173